CLOV stock · DXC stock

CLOV vs DXC

Clover Health Investments Corp (CLOV) versus DXC Technology Co (DXC) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

DXC Technology Co (DXC) is a information technology services company listed on US.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

Latest reported DXC revenue for 2025-03-31 was $12.87B. Net income was $396.0M. Revenue was down 5.8% from 2024-03-31 to 2025-03-31. DXC currently screens at market cap $2.92B and trailing P/E 7.6.

CLOV currently screens at market cap $1.55B. DXC currently screens at market cap $2.92B and trailing P/E 7.6.

Not investment advice. Open the CLOV and DXC stock pages for the full models.

Not investment advice.

Popular Stock Comparisons